Interviews with inspiring clinicians, scientists, researchers & geneticists in the field of epilepsy - out every Thursday.
Available on your podcast app & YouTube. **NOT FOR CLINICAL OR PATIENT DECISION MAKING**
For sponsorship opportunities contact us or click here for more information.
Looking for earlier episodes? You’ll find our full archive at torierobinson.com/epilepsy-sparks-insights
Could the immune system play a role in some treatment-resistant epilepsies? Prof. Colin Doherty discusses autoimmune epilepsies, early immunotherapy findings, and why epilepsy may involve more than abnormal electrical activity alone.
How may medical ketogenic therapy reduce anxiety, depression, and improve cognition? What might the effects be on cholesterol levels? What about support for those on the diet? Hear more from Dr. Manny Bagary.
How can ketones affect the brain in epilepsy? Dr. Manny Bagary explores the science behind medical ketogenic therapy, including brain excitability, neurotransmitters, mitochondria, inflammation, cognition and status epilepticus.
Exploring the complexities and benefits of ketogenic therapy for epilepsy, addressing misconceptions, patient selection, mechanisms of action, safety concerns, and the importance of multidisciplinary care - with Dr. Neha Kaul.
Dr. Jacob Pellinen discusses the Human Epilepsy Project, subtle focal seizures, delayed epilepsy diagnosis, learning difficulties, brain volume changes, and why epilepsy symptoms may begin years before recognised seizure onset.
Dr. Laurie Miller explains why memory problems happen in epilepsy, how different memory systems are affected, and the practical evidence-based strategies that may help improve everyday functioning.
What does epilepsy care look like when a clinician has to see more than 60 people in one day? Prof. Mamta Singh shares what high-volume epilepsy care really looks like in New Delhi - from specialist epilepsy clinics to outreach services across rural India.
Can exercise improve memory in people with an epilepsy? Jane Allendorfer shares early evidence from a six-week intervention and her newly completed randomised trial exploring how physical activity may drive cognitive improvement and changes in brain connectivity.
A deep dive into how combined MEG and high-density EEG can precisely localise seizure source in children with drug-resistant epilepsy, improving surgical decision-making and outcomes! With Christos Papadelis, Ph.D..
Exploring how epilepsy care goes beyond seizures, with a focus on mood, cognition, and the real-life priorities that shape quality of life, with Epilepsy Nurse Practicioner, Dr. Lucretia Long.
Many children suitable for epilepsy surgery are still not referred for evaluation. Asst. Prof. Juan Perez discusses the barriers behind this in Latin American and the steps being taken to address them.
What happens when epilepsy medication doesn’t work? Prof. John Duncan explains how treatment moves beyond medication, including surgery and neuromodulation, and why decisions must balance seizure control, risk, and quality of life.
Why does epilepsy still receive so little funding, attention and public understanding? Intellectual disability nurse Jay Price discusses underfunding, ignorance, misdiagnosis, and how co-produced training could improve care.
MRI scans can miss epilepsy lesions that may be treatable with surgery. Dr. Konrad Wagstyl discusses how his biotech AI tools trained on large MRI datasets are helping detect subtle brain abnormalities and identify surgical candidates earlier.
Generalised epilepsy is often described as involving the whole brain at once. Dr. Frederic Schaper discusses research suggesting shared brain networks may underlie these seizures - and how those networks overlap with targets used for deep brain stimulation.
Psychiatric symptoms are integral to the epilepsies and can shape disease course and quality of life. Dr. Andres M. Kanner explains how depression, anxiety, ADHD, and psychosis influence treatment decisions and outcomes.
Flash-back to our most popular episode! Epileptologist & neurologist Dr. Ángel Aledo-Serrano shares his thoughts regarding the antiseizure medication Levetiracetam/Keppra; its effectiveness and side-effects.
Who benefits from genetic testing in epilepsy, and how should uncertain results be interpreted? Christian Bosselmann discusses genome sequencing, variant interpretation, and why re-analysis over time matters.
Evidence-based insights on how patients and clinicians are already using generative AI in health care, and where the biggest risks and research gaps remain, with Charlotte Blease, PhD.